INTERPACE BIOSCIENCES, INC. (IDXG) › Net IncomeINTERPACE BIOSCIENCES, INC. (IDXG) — Net IncomeAnnual figures by period end, from SEC filings.2010-12-31: -$6.81M2011-12-31: -$11.91M2012-12-31: -$25.53M2013-12-31: -$4.57M2014-12-31: -$16.77M2015-12-31: -$13.62M2016-12-31: -$22.00M2017-12-31: $12.55M2018-12-31: -$12.70M2019-12-31: -$26.74M2020-12-31: -$26.45M2021-12-31: -$14.94M2022-12-31: -$21.96M2023-12-31: $1.95M2024-12-31: $6.70M2025-12-31: $24.57M$24.57M2010-12-31Net Income (USD)2025-12-31Period endedNet IncomeChange YoYSource filing2025-12-31$24.57M+266.7%2026-03-30From 2025-01-012024-12-31$6.70M+243.0%2026-03-30From 2024-01-012023-12-31$1.95M—2025-03-31From 2023-01-012022-12-31-$21.96M—2024-04-01From 2022-01-012021-12-31-$14.94M—2023-03-27From 2021-01-012020-12-31-$26.45M—2022-03-31From 2020-01-012019-12-31-$26.74M—2021-04-01From 2019-01-012018-12-31-$12.70M-201.2%2021-01-19From 2018-01-012017-12-31$12.55M—2021-01-19From 2017-01-012016-12-31-$22.00M—2021-01-19From 2016-01-012015-12-31-$13.62M—2021-01-19From 2015-01-012014-12-31-$16.77M—2021-01-19From 2014-01-012013-12-31-$4.57M—2015-03-05From 2013-01-012012-12-31-$25.53M—2014-03-06From 2012-01-012011-12-31-$11.91M—2013-03-15From 2011-01-012010-12-31-$6.81M—2012-03-09From 2010-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)